WallStreetZenWallStreetZen

NASDAQ: CELZ
Creative Medical Technology Holdings Inc Stock

$3.80+0.13 (+3.54%)
Updated Jul 18, 2024
CELZ Price
$3.80
Fair Value Price
$2.44
Market Cap
$5.12M
52 Week Low
$2.90
52 Week High
$10.28
P/E
-1.02x
P/B
0.56x
P/S
822.86x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.00k
Earnings
-$5.28M
Gross Margin
60%
Operating Margin
-58,624.39%
Profit Margin
-58,624.4%
Debt to Equity
0.04
Operating Cash Flow
-$5M
Beta
0
Next Earnings
Aug 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CELZ Overview

Creative Medical Technology Holdings, Inc. is a biotechnology company that focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Offerings include CaverStem to treat erectile dysfunction, FemCelz for the treatment of loss of genital sensitivity and dryness, StemSpine to treat chronic lower back pain, ImmCelz for the treatment of stroke patients, and OvaStem for treatment of female infertility. Creative Medical Technology was founded in 1998 and is based in Phoenix, AZ.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CELZ scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CELZ ($3.80) is overvalued by 55.58% relative to our estimate of its Fair Value price of $2.44 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CELZ ($3.80) is not significantly undervalued (55.58%) relative to our estimate of its Fair Value price of $2.44 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CELZ is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CELZ due diligence checks available for Premium users.

Be the first to know about important CELZ news, forecast changes, insider trades & much more!

CELZ News

Valuation

CELZ fair value

Fair Value of CELZ stock based on Discounted Cash Flow (DCF)
Price
$3.80
Fair Value
$2.44
Overvalued by
55.58%
CELZ ($3.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CELZ ($3.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CELZ is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CELZ price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.02x
Industry
-26.99x
Market
29.86x

CELZ price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.56x
Industry
6.19x
CELZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CELZ's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.0M
Profit Margin
0%
CELZ's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CELZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$9.6M
Liabilities
$391.0k
Debt to equity
0.04
CELZ's short-term assets ($9.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CELZ's short-term assets ($9.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CELZ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CELZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$896.9k
Investing
$6.5M
Financing
-$82.8k
CELZ's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CELZ vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CELZ$5.12M+3.68%-1.02x0.56x
VIRI$5.06M-9.62%-1.01x1.91x
SNPX$5.30M-4.02%-0.15x0.24x
BCDA$5.37M-5.14%-0.42x-2.36x
ONCO$4.87M+46.31%-0.09x-0.23x

Creative Medical Technology Holdings Stock FAQ

What is Creative Medical Technology Holdings's quote symbol?

(NASDAQ: CELZ) Creative Medical Technology Holdings trades on the NASDAQ under the ticker symbol CELZ. Creative Medical Technology Holdings stock quotes can also be displayed as NASDAQ: CELZ.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.

What is the 52 week high and low for Creative Medical Technology Holdings (NASDAQ: CELZ)?

(NASDAQ: CELZ) Creative Medical Technology Holdings's 52-week high was $10.28, and its 52-week low was $2.90. It is currently -63.04% from its 52-week high and 31.03% from its 52-week low.

How much is Creative Medical Technology Holdings stock worth today?

(NASDAQ: CELZ) Creative Medical Technology Holdings currently has 1,348,126 outstanding shares. With Creative Medical Technology Holdings stock trading at $3.80 per share, the total value of Creative Medical Technology Holdings stock (market capitalization) is $5.12M.

Creative Medical Technology Holdings stock was originally listed at a price of $18,750.00 in Dec 11, 2017. If you had invested in Creative Medical Technology Holdings stock at $18,750.00, your return over the last 6 years would have been -99.98%, for an annualized return of -75.76% (not including any dividends or dividend reinvestments).

How much is Creative Medical Technology Holdings's stock price per share?

(NASDAQ: CELZ) Creative Medical Technology Holdings stock price per share is $3.80 today (as of Jul 18, 2024).

What is Creative Medical Technology Holdings's Market Cap?

(NASDAQ: CELZ) Creative Medical Technology Holdings's market cap is $5.12M, as of Jul 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Creative Medical Technology Holdings's market cap is calculated by multiplying CELZ's current stock price of $3.80 by CELZ's total outstanding shares of 1,348,126.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.